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Introduction
Ductal adenocarcinoma accounts for 
85% to 90% of pancreatic tumors.1 Non-
Hodgkin’s lymphoma (NHL) frequently 
arises in extra-nodal sites, with about 50% 
of patients having extra-nodal involvement. 
Extra-nodal involvement is seen most 
commonly in the gastrointestinal tract and 
bone marrow. Involvement of the pancreas 
by NHL has been reported infrequently.2,3 
Only about 0.2 - 2% of patients with NHL 
have pancreatic involvement at the time of 
presentation.1,3,4 Histopathological examina-
tion is usually necessary to obtain a 
definitive diagnosis since symptoms and 
radiological features are similar to those of 
other pancreatic masses. We present a case 
of pancreatic lymphoma presenting as 
abdominal pain. The patient was diagnosed 
with a CT-guided biopsy and responded 
very well to chemotherapy.  
 
Case Report 
A 74-year-old Caucasian female patient 
presented with a past medical history 
significant for hypertension and arthritis. 
Her chief complaints were abdominal pain 
and weight loss. Pain was located in the 
epigastrium, sharp in nature, constant, and 
severe. Her symptoms began three months 
prior but worsened over time. She denied 
any fever or chills.  
On examination, the patient had diffuse 
abdominal tenderness greatest in the 
epigastric region. Laboratory data showed 
iron deficiency anemia, sodium of 127 
mEq/L, potassium of 2.9 mEq/L, and 
magnesium of 1.6 mEq/L. Liver function 
tests and lipase were normal. She underwent 
an abdominal ultrasound which showed a 
hypoechoic area in the spleen measuring 3.2 
x 3.7 x 2.7 cm and was thought to be a cyst. 
She had worsening gastrointestinal symp-
toms as well as 20 pound weight loss.  
A CT scan of the abdomen showed a soft 
tissue mass near the spleen originating from 
the tail of the pancreas with extension to and 
encasement of the superior mesenteric artery 
and celiac artery. At that point, unresectable 
adenocarcinoma of the pancreas was very 
high in the differential diagnosis and her 
options seemed to be limited. Her workup 
included a cancer antigen (CA) 19-9, which 
was 8, within the normal limit. Endoscopic 
ultrasound was performed with fine-needle 
aspiration (FNA) of the mass and sent for 
pathology. Her FNA was inconclusive and a 
CT-guided biopsy revealed a diffuse large B 
cell lymphoma, nongerminal center subtype 
with an immunoprofile positive for CD20, 
BCL-6, BCL-2, and negative for CD10. A 
positron emission tomography (PET) was 
negative in the neck, chest, and pelvis with 
no osseous or hepatic involvement of the 
metabolically-active neoplasm.  
The patient was started on chemotherapy 
with R-CHOP (Rituximab, Cyclophos-
phamide, Doxorubicin, Vincristine and 
Prednisone) for six cycles. She had an 
excellent response to her first two cycles of 
chemotherapy and her repeat PET scan was 
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consistent with complete response. After six 
cycles of chemotherapy, her symptoms 
resolved completely.  
 
Discussion 
Diffuse large B-cell lymphoma 
infrequently involves the pancreas.5,6 The 
presenting symptoms of pancreatic 
lymphoma are usually non-specific and 
include abdominal pain (83%), abdominal 
mass (58%), weight loss (50%), jaundice 
(37%), acute pancreatitis (12%), small 
bowel obstruction (12%), and diarrhea 
(12%).5,6 Clues suggesting the possibility of 
a primary pancreatic lymphoma include a 
lack of jaundice, constitutional symptoms 
(weight loss, fever, and night sweats), an 
elevated serum lactate dehydrogenase 
(LDH) or beta-2 microglobulin level, and a 
normal serum CA 19-9.  
Imaging is sometimes important in the 
diagnosis and staging of pancreatic 
lymphoma. CT scan is the modality 
commonly used for the detection of 
pancreatic lymphoma.7,8 It can present either 
as a tumor-like, well-circumscribed hypo-
echoic mass or as a diffuse enlargement 
infiltrating the pancreas.  
Pancreatic lymphoma might be 
distinguished from pancreatic adeno-
carcinoma by the absence of pancreatic duct 
involvement and the presence of 
surrounding lymphadenopathy.7,8 Primary 
pancreatic lymphomas typically are larger 
than 6 cm, and surrounding lymph-
adenopathy is common as with any 
lymphoma. Neither of these features, 
however, would exclude adenocarcinoma. It 
is unlikely to have a pancreatic adeno-
carcinoma above 10 cm in size; about 60% 
of pancreatic lymphomas are greater than 6 
cm in diameter.9  
The location of the tumor in the pancreas 
does not appear to be helpful in determining 
whether the mass is adenocarcinoma or 
lymphoma. Ultrasound or CT-guided fine 
needle biopsy of the pancreatic mass can 
help in the diagnosis of pancreatic 
lymphoma.7 In the absence of any 
pathognomonic clinical or radiological 
features, the diagnosis is established only on 
histopathological examination.  
Our patient was found to have a mass on 
CT scan. Endoscopic ultrasound-guided 
(EUS) biopsy did not help in diagnosis, so 
CT-guided biopsy was done and pancreatic 
lymphoma was diagnosed. A PET scan did 
not show any metastasis. The patient 
responded very well to chemotherapy with 
resolution of symptoms and clearing of 
tumor burden on imaging.  
Treatment and prognosis of pancreatic 
lymphoma are significantly different from 
those for pancreatic adenocarcinoma.7 
Anthracycline-based chemotherapy is the 
standard treatment for many types of NHL, 
and includes six to eight cycles of R-CHOP 
for patients of all ages.  
Diffuse large B-cell lymphoma rarely 
presents with synchronous pancreatic and 
splenic localizations. On literature review, 
no other cases of primary lymphoma of the 
pancreas confounded with a splenic 
involvement were found. Although the 
splenic mass was not biopsied, it resolved 
after treatment with chemotherapy. Primary 
pancreatic lymphoma should be considered 
in the differential diagnosis of pancreatic 
tumors and an attempt to obtain a tissue 
diagnosis is always necessary before 
proceeding to radical surgery, especially on 
young patients. 
 
Conclusion 
Pancreatic B-cell lymphoma is a rare 
tumor. Most of the tumors of the pancreas 
are adenocarcinoma. Pathologic diagnosis is 
important in distinguishing both of them. It 
is crucial to diagnose pancreatic lymphoma 
because the prognosis and treatment are 
different. Most cases of pancreatic lym-
phoma respond very well to chemotherapy. 
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EUS with fine needle aspiration is usually 
the diagnostic method used for the diagnosis 
of pancreatic malignancies; however, it has 
not been well studied in primary pancreatic 
lymphoma due to the rarity of the disease.
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